Hongchang Total Liabilities 2010-2024 | HCIL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Hongchang total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Hongchang total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$231B
Boston Scientific (BSX)	$155.5B
Stryker (SYK)	$147.4B
EssilorLuxottica (ESLOY)	$140.8B
Medtronic (MDT)	$112.8B
Lonza Group Ag (LZAGY)	$47.1B
Haleon (HLN)	$44.8B
GE HealthCare Technologies (GEHC)	$42.1B
Agilent Technologies (A)	$39B
ResMed (RMD)	$34.2B
Terumo (TRUMY)	$26.3B
Koninklijke Philips (PHG)	$23.5B
Zimmer Biomet Holdings (ZBH)	$20.6B
Insulet (PODD)	$20.2B
Baxter (BAX)	$17.1B
Sunny Optical Technology (SNPTF)	$11.3B
Smith & Nephew SNATS (SNN)	$11.2B
BellRing Brands (BRBR)	$9.5B
Bio-Rad Laboratories (BIO)	$8B
Demant (WILYY)	$7.9B
Lantheus Holdings (LNTH)	$5.6B
Prestige Consumer Healthcare (PBH)	$4.2B
ICU Medical (ICUI)	$4B
Envista Holdings (NVST)	$3.7B
Perrigo (PRGO)	$3.4B
Haemonetics (HAE)	$3.2B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.8B
LeMaitre Vascular (LMAT)	$2.3B